FindTrial
Sign In

From NAFLD to MAFLD: Comparison of Two Diagnostic Criteria in Clinical Studies

From NAFLD to MAFLD: Comparison of Two Diagnostic Criteria in Clinical Studies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059600
Enrollment
Unknown
Registered
2022-05-04
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic associated fatty liver disease(MAFLD)

Interventions

case series:None

Sponsors

The Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with fatty liver confirmed by imaging or biopsy in the Second Affiliated Hospital of Dalian Medical University from March 2021 to March 2022.

Exclusion criteria

Exclusion criteria: 1. Excessive alcohol consumption: alcohol intake > 40g/ day for men and > 20g/ day for women; 2. Complicated with viral hepatitis B/C, autoimmune and other liver damage factors.

Design outcomes

Primary

MeasureTime frame
C-reactive protein;platelet;fasting blood glucose;HbA1c;alanine aminotransferase;aspartate aminotransferase;insulin;cholesterol;triglyceride;low-density lipoprotein;—

Countries

China

Contacts

Public ContactYing Li
yingli0209@163.com+86 17709870657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026